PITTSBURGH, March 23, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Effexor® SR ...

Approval in moderate-to-severe patients was based on pivotal trial results showing over four times more Dupixent patients experienced sustained disease remission through Week 36 compared with placebo ...

Among the changes, the new system lets support recipients flexibly replace their guardians, and it will allow for digital ...

The White House is preparing for a situation in Japan that could be "deadly for decades," a U.S. official tells ABC News.